                         SEQUENCE LISTING

<110>  THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE 
       SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
 
<120>  TP5, A PEPTIDE INHIBITOR OF ABERRANT AND HYPERACTIVE CDK5/P25 AS 
       TREATMENT FOR CANCER

<130>  746530

<150>  US 62/767,230
<151>  2018-11-14

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  1

Lys Glu Ala Phe Trp Asp Arg Cys Leu Ser Val Ile Asn Leu Met Ser 
1               5                   10                  15      


Ser Lys Met Leu Gln Ile Asn Ala Tyr Ala Arg Ala Ala Arg Arg Ala 
            20                  25                  30          


Ala Arg Arg 
        35  


<210>  2
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  2

Phe Trp Asp Arg Cys Leu Ser Gly Lys Met Ser Ser Lys Gly Gly Gly 
1               5                   10                  15      


Ile Asn Ala Tyr Ala Arg Ala Ala Arg Arg Ala Ala Arg Arg 
            20                  25                  30  


